|
Market Closed -
Nasdaq
21:00:00 15/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.670 USD | -5.66% |
|
-12.20% | -48.16% |
Company Valuation: Bicycle Therapeutics plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,790 | 878.8 | 767 | 966.6 | 491.1 | 256.9 | - | - |
| Change | - | -50.89% | -12.72% | 26.03% | -49.19% | -47.7% | - | - |
| Enterprise Value (EV) 1 | 1,381 | 570 | 280.6 | 91.11 | -122.9 | -255.9 | -146.5 | -27.89 |
| Change | - | -58.72% | -50.76% | -67.53% | -234.87% | -108.26% | 42.77% | 80.96% |
| P/E | -22.8x | -7.79x | -3.56x | -4.83x | -2.24x | -1.41x | -1.57x | -1.39x |
| PBR | 4.41x | 3.24x | 2.07x | 1.03x | 0.81x | 0.46x | 0.55x | 0.67x |
| PEG | - | -0.2x | -0.1x | 0.1x | -0.25x | 0.1x | 0.2x | -0.1x |
| Capitalization / Revenue | 153x | 60.8x | 28.4x | 27.4x | 6.77x | 14.7x | 38.4x | 16.5x |
| EV / Revenue | 118x | 39.4x | 10.4x | 2.58x | -1.69x | -14.6x | -21.9x | -1.79x |
| EV / EBITDA | -21.5x | -5.05x | -1.53x | -0.45x | 0.51x | 1.85x | 0.85x | 0.16x |
| EV / EBIT | -21x | -4.89x | -1.48x | -0.43x | 0.5x | 1.37x | 0.77x | 0.13x |
| EV / FCF | -82.1x | -5.42x | -4.42x | -0.55x | 0.49x | 1.67x | 1.01x | 0.18x |
| FCF Yield | -1.22% | -18.4% | -22.6% | -182% | 205% | 59.8% | 99.3% | 545% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.67 | -3.8 | -5.08 | -2.9 | -3.16 | -2.602 | -2.341 | -2.641 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 11.7 | 14.46 | 26.98 | 35.28 | 72.59 | 17.53 | 6.689 | 15.61 |
| EBITDA 1 | -64.21 | -113 | -183.4 | -202.7 | -240.6 | -138.5 | -172.9 | -172.9 |
| EBIT 1 | -65.62 | -116.7 | -189.9 | -209.9 | -247.1 | -187.2 | -190.1 | -209.9 |
| Net income 1 | -66.82 | -112.7 | -180.7 | -169 | -219 | -172.1 | -175.1 | -199 |
| Net Debt 1 | -408.8 | -308.8 | -486.3 | -875.5 | -614 | -512.8 | -403.4 | -284.8 |
| Reference price 2 | 60.870 | 29.600 | 18.080 | 14.000 | 7.080 | 3.670 | 3.670 | 3.670 |
| Nbr of stocks (in thousands) | 29,400 | 29,689 | 42,422 | 69,046 | 69,368 | 69,993 | - | - |
| Announcement Date | 01/03/22 | 28/02/23 | 20/02/24 | 25/02/25 | 17/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.49x | -13.72x | 1.74x | - | 257M | |
| 20.63x | 7.28x | 14.62x | 1.44% | 69.18B | |
| 32.28x | 9.34x | 45.05x | 0.04% | 62B | |
| -76.7x | 14.8x | -71.37x | -.--% | 26.19B | |
| 29.77x | 6.32x | 16.41x | -.--% | 25.75B | |
| -15.03x | 5.62x | -7.06x | -.--% | 24.29B | |
| 26.45x | 5.03x | 16.73x | -.--% | 19.84B | |
| 44.88x | 16.47x | 33.42x | 0.34% | 15.65B | |
| -15.8x | 3569.89x | -18.25x | -.--% | 13.88B | |
| 1267.62x | 36.68x | 797.93x | -.--% | 14.09B | |
| Average | 131.26x | 365.77x | 82.92x | 0.2% | 27.11B | |
| Weighted average by Cap. | 76.31x | 192.50x | 51.75x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BCYC Stock
- Valuation Bicycle Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
